United States· US:37662-2297_f1f51e7a-f305-72a7-e053-2a95a90a0756
Syzygium Jambolanum
A medicinal product containing syzygium cumini seed, registered in United States by Hahnemann Laboratories, INC..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SYZYGIUM CUMINI SEED
- Manufacturer
- Hahnemann Laboratories, INC.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc113766222971200 PELLET in 1 VIAL, GLASS (37662-2297-1)
- ndc1137662229721200 PELLET in 1 BOTTLE, GLASS (37662-2297-2)
- ndc1137662229734000 PELLET in 1 BOTTLE, GLASS (37662-2297-3)
- ndc1137662-2297-1
- ndc1137662-2297-2
- ndc1137662-2297-3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e3c836ce-e950-4105-b7cd-c5beefd900d1 GET /v1/drugs/e3c836ce-e950-4105-b7cd-c5beefd900d1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "6",
"substance": "SYZYGIUM CUMINI SEED",
"productndc": "37662-2297",
"dosage_form": "PELLET",
"dea_schedule": null,
"strength_unit": "[hp_C]/1",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about syzygium cumini seed.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.